Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity.
about
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsThe adenovirus genome contributes to the structural stability of the virionAdenovirus membrane penetration: Tickling the tail of a sleeping dragonInflammasome control of viral infectionConformational changes in the adenovirus hexon subunit responsible for regulating cytoplasmic dynein recruitment.Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.Ultrastructure of adenovirus keratitis.Proteolytic disassembly of viral outer capsid proteins is crucial for reovirus-mediated type-I interferon induction in both reovirus-susceptible and reovirus-refractory tumor cells.Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.The amphipathic helix of adenovirus capsid protein VI contributes to penton release and postentry sorting.Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response.Decreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses.Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors.
P2860
Q26782083-9B10ABF5-B350-4762-BE9D-7BE889412F65Q26825101-8068BF3E-4F02-4876-96D9-60F809937190Q28084476-51F94FB0-CCBE-44E6-9810-B3EF19D493CEQ28088727-0AC18CD1-080F-4EEE-BB24-B33DFEF72997Q30616830-964FF2FA-AC4B-4BCE-AEA5-4819718969CFQ34594959-408F0983-C550-40BB-A649-C9176AA59921Q34986475-062D0920-B7C7-4804-A4A4-B8599EA35234Q35249529-A9A952A5-2727-4022-974B-526427538E62Q36852526-D98570FF-F75E-4FFA-8FC3-70C1B2D72C84Q38932365-8AC8F5D4-487A-407B-9204-287E2D386ED5Q40042419-A535DC5B-BDCD-48C5-9B01-795CDA38F8A1Q40057846-28F4632B-544B-4C0D-8783-D03AA2135C1DQ40256121-E78DC1F9-BBA6-429C-8C7C-1F001F06501FQ47558367-0BE55A8C-1952-448C-9C52-965114BB7B7A
P2860
Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Late endosomal trafficking of ...... nts antiviral innate immunity.
@ast
Late endosomal trafficking of ...... nts antiviral innate immunity.
@en
Late endosomal trafficking of ...... nts antiviral innate immunity.
@nl
type
label
Late endosomal trafficking of ...... nts antiviral innate immunity.
@ast
Late endosomal trafficking of ...... nts antiviral innate immunity.
@en
Late endosomal trafficking of ...... nts antiviral innate immunity.
@nl
prefLabel
Late endosomal trafficking of ...... nts antiviral innate immunity.
@ast
Late endosomal trafficking of ...... nts antiviral innate immunity.
@en
Late endosomal trafficking of ...... nts antiviral innate immunity.
@nl
P2860
P356
P1433
P1476
Late endosomal trafficking of ...... nts antiviral innate immunity.
@en
P2093
Jeffrey E Teigler
Jonathan C Kagan
P2860
P304
10354-10363
P356
10.1128/JVI.00936-14
P407
P577
2014-07-02T00:00:00Z